Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive ...

Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...

Uneasiness continues to weigh on tech hiring activity, according to CompTIA, the leading global provider of vendor-neutral information technology (IT) training and certification ...

The National Business Research Institute (NBRI) is pleased to welcome ALL WEST COMMUNICATIONS to the NBRI Circle of Excellence. The NBRI Circle of Excellence Award recognizes organizations that ...

Millar Western Forest Products Ltd. was registered this past week by Greg McFarlane and Hal Danchilla, both consultants from Integrated Strategic Partners Inc.

DataM Intelligence | competitive Intelligence Gene therapies, exon-skipping drugs and next-gen steroids are reshaping Duchenne muscular dys ...

Late-stage results Otsuka presented in IgA nephropathy triggered a sell-off in Vera shares. Elsewhere, investors scrutinized ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Protara, hoping to ultimately transition to a commercial stage company, snagged a chief commercial officer in Bill Conkling, ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the and ...